Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol. [electronic resource]
Producer: 20050215Description: 91-6 p. digitalISSN:- 0278-5846
- Adult
- Antipsychotic Agents -- therapeutic use
- Benzamides
- Drug Resistance
- Dyskinesia, Drug-Induced -- psychology
- Female
- Haloperidol -- therapeutic use
- Humans
- Male
- Neostriatum -- drug effects
- Piperazines -- therapeutic use
- Psychiatric Status Rating Scales
- Psychotic Disorders -- drug therapy
- Pyrrolidines
- Radiopharmaceuticals
- Receptors, Dopamine D2 -- drug effects
- Single-Blind Method
- Thiazoles -- therapeutic use
- Tomography, Emission-Computed, Single-Photon
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.